A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer

Status Not yet recruiting

Clinical Trial Summary

Clinical Trial Description

The purpose of this study is to evaluate the role of quantitative MR imaging and blood-based biomarkers to measure liver function in patients receiving radiation therapy for liver cancer or cancer that has spread to the liver. The feasibility of using MR imaging to monitor liver function at baseline and following liver radiation therapy will be determined. Information from MR images and blood samples, along with patient questionnaires, will be used. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06144827
Study type	Interventional
Source	Montefiore Medical Center
Contact	Rafi Kabarriti, MD
Phone	7189207750
Email	rkbarri@montefiore.org
Status	Not yet recruiting
Phase	N/A
Start date	April 2024
Completion date	April 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04059809` - Photobiomodulation for Breast Cancer Radiodermatitis	Phase 2/Phase 3
Recruiting	`NCT05543239` - Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation on Radiotherapy-Related Neuropathic Pain	N/A
Terminated	`NCT04535908` - Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.	N/A
Recruiting	`NCT04115267` - Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies
Recruiting	`NCT05820633` - Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.	N/A
Active, not recruiting	`NCT05880446` - PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)	N/A
Recruiting	`NCT05724004` - Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)	N/A
Recruiting	`NCT04612907` - Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer	N/A
Recruiting	`NCT05762900` - Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients	Phase 2
Recruiting	`NCT03613506` - The Role and Intervention of TGF-β in Abdominal Radiation Injury	Phase 2
Completed	`NCT06353724` - Comparison Between the Effect of Using Conventional and Digital Oral Positional Radiation Stent	N/A
Not yet recruiting	`NCT05548504` - Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC	Phase 2
Recruiting	`NCT05224297` - Patient Experience Data in Radiation Oncology
Recruiting	`NCT05776147` - Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study
Completed	`NCT04842409` - Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery
Recruiting	`NCT03742687` - Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC	N/A
Not yet recruiting	`NCT05614700` - Prostate Reirradiation Toxicity Outcomes Feasibility Study	N/A
Completed	`NCT04027543` - Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）
Recruiting	`NCT05354596` - A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).	N/A
Recruiting	`NCT03378856` - Evaluation of Technological Innovation in Radiotherapy